Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992
Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007
Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
NEJM 356:29-38, Schade,R.,et al, 2007
Psychiatric Side Effects During Methysergide Treatment
JNNP 76:1037-1038, Cittadini,E. &Goadsby,P.J., 2005
Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005
Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Drugs for Migraine
The Medical Letter 37:17-20, , 1995
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Pleural and Retroperitoneal Fibrosis from Dihydroergotamine
NEJM 321:1760, Malaquin,F.,et al, 1989
Fibrotic Processes Associated with Long-Term Ergotamine Therapy
NEJM 311:601-602, Robert,M.,et al, 1984
Arterial Complications of Migraine Treatment with Methysergide & Parenteral Ergotamine
BMJ 285:260-261, Joyce,D.A.,et al, 1982
Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977
Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977